UTAH MED PRODS INC holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 17,116 | $959,181 | 0.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 12, 2025 |
| June 30, 2025 | 17,478 | $994,848 | 0.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 8, 2025 |
| Sept. 30, 2025 | 17,193 | $1,082,643 | 0.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 3, 2025 |
| Dec. 31, 2025 | 21,344 | $1,194,410 | 0.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 11, 2026 |
| March 31, 2026 | 25,564 | $1,584,712 | 0.02% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 11, 2026 |
| June 30, 2026 | 23,933 | $1,650,898 | 0.02% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 3, 2026 |
| Sept. 30, 2026 | 20,823 | $1,541,943 | 0.02% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Oct. 28, 2026 |
7 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.